365 related articles for article (PubMed ID: 18096439)
21. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
[TBL] [Abstract][Full Text] [Related]
22. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus.
Pacifico RJ; Wang KK; Wongkeesong LM; Buttar NS; Lutzke LS
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):252-7. PubMed ID: 15017665
[TBL] [Abstract][Full Text] [Related]
23. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
24. Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy.
Wolfsen HC; Hemminger LL; DeVault KR
BMC Gastroenterol; 2004 Aug; 4():18. PubMed ID: 15327696
[TBL] [Abstract][Full Text] [Related]
25. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
26. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol.
Kariv R; Plesec TP; Goldblum JR; Bronner M; Oldenburgh M; Rice TW; Falk GW
Clin Gastroenterol Hepatol; 2009 Jun; 7(6):653-8; quiz 606. PubMed ID: 19264576
[TBL] [Abstract][Full Text] [Related]
27. Barrett's esophagus: management of high-grade dysplasia and cancer.
Ruol A; Zaninotto G; Costantini M; Battaglia G; Cagol M; Alfieri R; Epifani M; Ancona E
J Surg Res; 2004 Mar; 117(1):44-51. PubMed ID: 15013713
[TBL] [Abstract][Full Text] [Related]
28. Barrett's esophagus: pathologic considerations and implications for treatment.
Rice TW; Mendelin JE; Goldblum JR
Semin Thorac Cardiovasc Surg; 2005; 17(4):292-300. PubMed ID: 16428035
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors of coexisting cancer in Barrett's high-grade dysplasia.
Tharavej C; Hagen JA; Peters JH; Portale G; Lipham J; DeMeester SR; Bremner CG; DeMeester TR
Surg Endosc; 2006 Mar; 20(3):439-43. PubMed ID: 16437272
[TBL] [Abstract][Full Text] [Related]
30. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE
Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761
[TBL] [Abstract][Full Text] [Related]
31. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
Gilbert S; Jobe BA
Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis.
Pohl H; Sonnenberg A; Strobel S; Eckardt A; Rösch T
Gastrointest Endosc; 2009 Oct; 70(4):623-31. PubMed ID: 19394011
[TBL] [Abstract][Full Text] [Related]
33. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
Montgomery E; Goldblum JR; Greenson JK; Haber MM; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Zahurak ML; Hart J
Hum Pathol; 2001 Apr; 32(4):379-88. PubMed ID: 11331954
[TBL] [Abstract][Full Text] [Related]
34. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.
Dunbar KB; Spechler SJ
Am J Gastroenterol; 2012 Jun; 107(6):850-62; quiz 863. PubMed ID: 22488081
[TBL] [Abstract][Full Text] [Related]
35. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy.
Abela JE; Going JJ; Mackenzie JF; McKernan M; O'Mahoney S; Stuart RC
Am J Gastroenterol; 2008 Apr; 103(4):850-5. PubMed ID: 18371135
[TBL] [Abstract][Full Text] [Related]
36. Another strike against esophagectomy for high-grade dysplasia in Barrett's esophagus?
Wani S; Sharma P
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):128-9. PubMed ID: 18237863
[No Abstract] [Full Text] [Related]
37. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
Srivastava A; Hornick JL; Li X; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD
Am J Gastroenterol; 2007 Mar; 102(3):483-93; quiz 694. PubMed ID: 17338734
[TBL] [Abstract][Full Text] [Related]
38. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
[TBL] [Abstract][Full Text] [Related]
39. [Endoscopic treatment of Barrett's oesophagus].
Boyer J
Ann Chir; 2006 Jan; 131(1):7-11. PubMed ID: 16376846
[TBL] [Abstract][Full Text] [Related]
40. Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up.
Montgomery E; Bronner MP; Greenson JK; Haber MM; Hart J; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Goldblum JR
Am J Gastroenterol; 2002 Jan; 97(1):27-31. PubMed ID: 11808966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
